CYTEFURACIL Trademark

Trademark Overview


On Thursday, February 13, 1997, a trademark application was filed for CYTEFURACIL with the United States Patent and Trademark Office. The USPTO has given the CYTEFURACIL trademark a serial number of 75291127. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, December 11, 1997. This trademark is owned by Glaxo Group Limited. The CYTEFURACIL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer

General Information


Serial Number75291127
Word MarkCYTEFURACIL
Filing DateThursday, February 13, 1997
Status601 - ABANDONED - EXPRESS
Status DateThursday, December 11, 1997
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, August 4, 1999
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB

Trademark Events


Event DateEvent Description
Thursday, December 11, 1997ABANDONMENT - EXPRESS MAILED
Thursday, December 11, 1997ASSIGNED TO EXAMINER